Key facts
- It has raised $689.5M across 1 recorded rounds; the latest was PIPE ($689.5M) in Sep 2024.
- 1 institutional filer reports fund marks on BioMarin Pharmaceutical across 4 filings.
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for BioMarin Pharmaceutical
Create free account
No card required
Funding rounds
1 roundsSep 2024PIPE$689.5M▮
About BioMarin Pharmaceutical
- Industry
- Drug Discovery
PA Mark — not yet priced
BioMarin Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in BioMarin Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
1 filers · latest Apr 20261 SEC-registered fund reported 4 fair-value marks on BioMarin Pharmaceutical between Apr 2025 and Apr 2026. Filer-level marks and implied $/share are available to Pro members.